Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Anesthesia and Respiratory Devices Market by Product [Anesthesia (Anesthesia Delivery Machines, Anesthesia Disposables & Accessories, Anesthesia Monitors, and Anesthesia Information Management Systems) and Respiratory Devices (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, and Consumables & Accessories)] and End User (Hospitals, Ambulatory Service Centers, Homecare, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_18342

Pages: 214

Formats:

Feb 2018 | 4565 Views

Charts: 116

Tables: 96

Author(s): Tenzin Kunsel and Garima Chandra

Purchase Option


Anesthesia and Respiratory Devices Market Overview:

Respiratory care devices are used for diagnosis and treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. These devices provide enhanced care to patients suffering from such acute and chronic respiratory diseases. Since the last decade, increase in prevalence of respiratory diseases is a pivotal factor that drives the respiratory care devices market. Anesthesia devices are used during surgical procedures to control pain, breathing, blood pressure, blood flow, and heart rate & rhythm. A medical state in patients induced by use of anesthesia leads to loss of sensation or awareness, which can include analgesia (relief from or prevention of pain), paralysis (muscle relaxation), amnesia (loss of memory), or unconsciousness. The global anesthesia and respiratory devices market was valued at $23,446 million in 2016, and is estimated to reach $38,298 million by 2023, registering a CAGR of 7.2% from 2017 to 2023.

Increase in prevalence of respiratory diseases, rapid urbanization, upsurge in number of surgical procedures, rise in pollution level, growth in geriatric population, and increase in tobacco consumption drive the anesthesia and respiratory devices market. In addition, factors such as innovations with regard to respiratory care devices and governmental support for the launch and approval of these devices further fuel the market growth. Moreover, high demand for therapeutic devices for homecare settings and increase in healthcare expenditures are expected to provide lucrative growth opportunities for the market. However, the presence of a large pool of undiagnosed population, risks associated with certain therapeutic and diagnostic devices for neonates, and low adoption rate of new technologies, owing to reluctance from the physicians for treatment, restrain the market growth.

Product Segment Review

Based on the product type, it is bifurcated into anesthesia and respiratory devices. Respiratory devices segment is the dominant segment in the market, owing to the high prevalence rate of respiratory diseases and availability of advanced respiratory devices.

Get more information on this report : Request Sample Pages

End User Segment Review

Based on end user, the market is segmented into hospitals, ambulatory service centers, homecare, and clinics. The hospitals segment is the dominant segment, as they are equipped with specialized and advanced anesthesia and respiratory devices. However, clinics are expected to be grow at the highest CAGR.

Get more information on this report : Request Sample Pages

Global Anesthesia and Respiratory Devices Market: Key Geographical Segment

Based on region, the anesthesia and respiratory devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2016, and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global anesthesia and respiratory devices market include Teleflex Incorporated, SunMed, Smiths Group Plc., ResMed Inc., Medtronic Plc., Masimo Corporation, Koninklijke Philips N.V., Invacare Corporation, Hamilton Medical AG, GE Healthcare, Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, Chart Industries Inc., Becton, Dickinson and Company, Ambu S/A, and 3M Company.

Other prominent players in the value chain include Aircraft Medical, Verathon Inc., Karl Storz GmbH & Co. KG, Pentax, 3B Medical, Inc., Medline Industries Inc., Acare Technology Co., Ltd., Allied Healthcare Inc., Hill-Rom Holdings Inc., and Rotech Healthcare Inc.

Key Benefits for Stakeholders

  • This report entails a detailed quantitative analysis of the current trends from 2016 to 2023 of the global anesthesia and respiratory devices market to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to product, end user, and region.
  • In-depth analysis based on geography helps in understanding the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Anesthesia And Respiratory Devices Market Key Segments:

By Product Type

  • Anesthesia Devices
    • Anesthesia Delivery Machines
    • Anesthesia Disposables & Accessories
      • Anesthesia Circuits
      • Anesthesia Masks
      • Resuscitators
      • Laryngoscopes
      • Flexible Intubation Scopes
      • Supraglottic Airways
      • Ventilator Circuits
      • HME
      • Regional Anesthesia and Pain Devices
      • Others
    • Anesthesia Monitors
      • Basic Anesthesia Monitors
      • Advanced Anesthesia Monitors
      • Integrated Anesthesia Workstations
    • Anesthesia Information Management Systems (AIMS)
  • Respiratory Devices
    • Therapeutic Devices
      • Positive Airway Pressure (PAP) Devices
      • Continuous Positive Airway Pressure (CPAP) Devices
      • Automatic Positive Airway Pressure (APAP) Devices
      • Bilevel Positive Airway Pressure (BPAP) Devices
    • Masks
      • Nasal Masks
      • Full-face Masks
      • Nasal Pillow Masks
      • Oral Masks
    • Ventilators
    • Nebulizers
    • Humidifiers
    • Oxygen concentrators
      • Fixed Oxygen Concentrators
      • Portable Oxygen Concentrators
    • Inhalers
      • Dry Powder Inhalers
      • Metered Dose Inhalers
      • Soft Mist Inhaler
    • Reusable Resuscitators
      • Adult Resuscitators
      • Infant/Neonatal Resuscitators
    • Nitric Oxide Delivery Units
    • Capnographs
    • Gas Analyzers
    • Oxygen Hoods
  • Monitoring Devices
    • Pulse Oximeters
      • Pediatric Pulse Oximeters
      • Wrist-Worn Pulse Oximeters
      • Handheld Oximeter
      • Fingertip Pulse Oximeter
      • Table-top or Bedside Pulse Oximeters
  • Diagnostic Devices
    • Spirometers
    • Polysomnography (PSG) Devices
    • Peak Flow Meters
  • Consumables & Accessories
    • Disposable Resuscitators
    • Tracheostomy Tubes
    • Nasal Cannulas
    • Disposable Masks
    • Others

By End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Service Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key Findings

3.2.1. Top Winning Strategies
3.2.2. Top Investment Pockets

3.3. Top Player Positioning, 2016
3.4. Porter’s Five Forces Analysis
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Growth in elderly population throughout the world
3.5.1.2. Rise in prevalence of respiratory diseases
3.5.1.3. Increase in cases of preterm birth
3.5.1.4. Technological advancement in anesthesia monitoring
3.5.1.5. Increase in number of surgeries

3.5.2. Restrains

3.5.2.1. High equipment cost
3.5.2.2. Regulatory compliances
3.5.2.3. Lack of awareness in developing region
3.5.2.4. Harmful effects of respiratory devices on neonates

3.5.3. Opportunities

3.5.3.1. Increased demand for quality healthcare monitoring
3.5.3.2. Increase in awareness and improvement in the healthcare infrastructure in emerging nations create huge opportunities for manufacturers
3.5.3.3. Rise in the demand for home care respiratory devices

CHAPTER 4: ANESTHESIA AND RESPIRATORY DEVICES MARKET BY PRODUCT

4.1. Overview

4.1.1. Market Size and Forecast

4.2. Anesthesia Devices

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Anesthesia Delivery Machines

4.2.4.1. Market size & forecast

4.2.5. Anesthesia Disposables and Accessories

4.2.5.1. Market size & forecast

4.2.5.1.1. Anesthesia Circuits

4.2.5.1.1.1. Market size and forecast

4.2.5.1.2. Anesthesia Masks

4.2.5.1.2.1. Market size and forecast

4.2.5.1.3. Resuscitators

4.2.5.1.3.1. Market size and forecast

4.2.5.1.4. Laryngoscopes

4.2.5.1.4.1. Market size and forecast

4.2.5.1.5. Flexible Intubation Scopes

4.2.5.1.5.1. Market size and forecast

4.2.5.1.6. Supraglottic Airways

4.2.5.1.6.1. Market size and forecast

4.2.5.1.7. Ventilator Circuits

4.2.5.1.7.1. Market size and forecast

4.2.5.1.8. Heat and moisture exchangers (HME's)

4.2.5.1.8.1. Market size and forecast

4.2.5.1.9. Regional Anesthesia and Pain Devices

4.2.5.1.9.1. Market size and forecast

4.2.5.1.10. Others

4.2.5.1.10.1. Market size and forecast

4.2.6. Anesthesia Monitors

4.2.6.1. Market size & forecast

4.2.6.1.1. Basic Anesthesia Monitors

4.2.6.1.1.1. Market size and forecast

4.2.6.1.2. Advanced Anesthesia Monitors

4.2.6.1.2.1. Market size and forecast

4.2.6.1.3. Integrated Anesthesia Workstations

4.2.6.1.3.1. Market size and forecast

4.2.7. Anesthesia Information Management Systems (AIMS)

4.2.7.1. Market size & forecast

4.3. RESPIRATORY DEVICE

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Therapeutic Devices

4.3.4.1. Market size and forecast
4.3.4.2. Positive Airway Pressure (PAP) Devices

4.3.4.2.1. Market size and forecast
4.3.4.2.2. Continuous Positive Airway Pressure (CPAP) Devices

4.3.4.2.2.1. Market size and forecast

4.3.4.2.3. Bilevel PAP (BPAP) Devices

4.3.4.2.3.1. Market size and forecast

4.3.4.2.4. Automatic Positive Airway Pressure (APAP) Devices

4.3.4.2.4.1. Market size and forecast

4.3.4.3. Masks

4.3.4.3.1. Market size and forecast
4.3.4.3.2. Nasal Masks

4.3.4.3.2.1. Market size and forecast

4.3.4.3.3. Full-face Masks

4.3.4.3.3.1. Market size and forecast

4.3.4.3.4. Nasal pillow Masks

4.3.4.3.4.1. Market size and forecast

4.3.4.3.5. Oral Masks

4.3.4.3.5.1. Market size and forecast

4.3.4.4. Ventilators

4.3.4.4.1. Market size and forecast
4.3.4.4.2. Adult Ventilators

4.3.4.4.2.1. Market size and forecast

4.3.4.4.3. Infant/neonatal Ventilators

4.3.4.4.3.1. Market size and forecast

4.3.4.5. Nebulizers

4.3.4.5.1. Market size and forecast

4.3.4.6. Humidifiers

4.3.4.6.1. Market size and forecast

4.3.4.7. Oxygen concentrators

4.3.4.7.1. Market size and forecast
4.3.4.7.2. Fixed Oxygen Concentrators

4.3.4.7.2.1. Market size and forecast
4.3.4.7.2.2. Portable Oxygen Concentrators
4.3.4.7.2.3. Market size and forecast

4.3.4.8. Inhalers

4.3.4.8.1. Market size and forecast
4.3.4.8.2. Dry Powder Inhalers (DPIs)

4.3.4.8.2.1. Market size and forecast

4.3.4.8.3. Metered Dose Inhalers (MDIs)

4.3.4.8.3.1. Market size and forecast

4.3.4.8.4. Soft Mist Inhalers (SMIs)

4.3.4.8.4.1. Market size and forecast

4.3.4.9. Reusable Resuscitators

4.3.4.9.1. Market size and forecast
4.3.4.9.2. Adult Resuscitators

4.3.4.9.2.1. Market size and forecast

4.3.4.9.3. Infant/neonatal Resuscitators

4.3.4.9.3.1. Market size and forecast

4.3.4.10. Nitric Oxide Delivery Units

4.3.4.10.1. Market size and forecast

4.3.4.11. Capnographs

4.3.4.11.1. Market size and forecast

4.3.4.12. Gas Analyzers

4.3.4.12.1. Market size and forecast

4.3.4.13. Oxygen Hoods

4.3.4.13.1. Market size and forecast

4.3.5. Monitoring Devices

4.3.5.1. Pulse Oximeters

4.3.5.1.1. Market size and forecast
4.3.5.1.2. Pediatric Pulse Oximeters

4.3.5.1.2.1. Market size and forecast

4.3.5.1.3. Wrist-worn Pulse Oximeters

4.3.5.1.3.1. Market size and forecast

4.3.5.1.4. Hand-held Pulse Oximeters

4.3.5.1.4.1. Market size and forecast

4.3.5.1.5. Fingertip Pulse Oximeters

4.3.5.1.5.1. Market size and forecast

4.3.5.1.6. Table-top/bedside Pulse Oximeters

4.3.5.1.6.1. Market size and forecast

4.3.6. Diagnostic Devices

4.3.6.1. Market size and forecast
4.3.6.2. Spirometers

4.3.6.2.1. Market size and forecast

4.3.6.3. Polysomnography (PSG) Devices

4.3.6.3.1. Market size and forecast
4.3.6.3.2. Peak Flow Meters

4.3.6.3.2.1. Market size and forecast

4.3.7. Consumables and Accessories

4.3.7.1. Market size and forecast
4.3.7.2. Disposable Masks

4.3.7.2.1. Market size and forecast

4.3.7.3. Disposable Resuscitators

4.3.7.3.1. Market size and forecast

4.3.7.4. Tracheostomy Tubes

4.3.7.4.1. Market size and forecast

4.3.7.5. Nasal Cannulas

4.3.7.5.1. Market size and forecast

4.3.7.6. Others

4.3.7.6.1. Market size and forecast

CHAPTER 5: ANESTHESIA AND RESPIRATORY DEVICES MARKET BY END USERS

5.1. Overview

5.1.1. Market Size and Forecast

5.2. Hospitals

5.2.1. Market size & forecast

5.3. Ambulatory service centers (ASC)

5.3.1. Market size & forecast

5.4. Homecare

5.4.1. Market size and forecast

5.5. Clinics

5.5.1. Market size & forecast

CHAPTER 6: ANESTHESIA AND RESPIRATORY DEVICES MARKET BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. Key market trends
6.2.3. Growth factors and opportunities
6.2.4. North America Market size and forecast
6.2.5. U.S. Market size and forecast
6.2.6. Canada Market size and forecast
6.2.7. Mexico Market size and forecast

6.3. Europe

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Europe market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. UK market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Spain market size and forecast
6.3.9. Rest of Europe market size and forecast

6.4. Asia-Pacific

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Asia-Pacific market size and forecast
6.4.4. Japan Market size and forecast
6.4.5. China Market size and forecast
6.4.6. Australia Market size and forecast
6.4.7. India Market size and forecast
6.4.8. South Korea Market size and forecast
6.4.9. Rest of the Asia-Pacific Market size and forecast

6.5. LAMEA

6.5.1. Key Market Trends
6.5.2. Key growth factors and opportunities
6.5.3. LAMEA market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast

CHAPTER 7: COMPANY PROFILES

7.1. 3M Company

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. Ambu S/A

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance

7.3. Becton, Dickinson and Company

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Chart Industries Inc.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance

7.5. Drägerwerk AG & Co. KGaA

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance

7.6. Fisher & Paykel Healthcare Limited

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments

7.7. GE Healthcare (A healthcare division Of GE Company)

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Hamilton Medical AG

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Product portfolio

7.9. Invacare Corporation

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. Koninklijke Philips N.V.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

7.11. Masimo Corporation

7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Product portfolio
7.11.4. Business performance

7.12. Medtronic Plc.

7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Product portfolio
7.12.5. Business performance

7.13. ResMed Inc.

7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Product portfolio
7.13.4. Business performance
7.13.5. Key strategic moves and developments

7.14. Smiths Group Plc.

7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Product portfolio
7.14.5. Business performance

7.15. SunMed

7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Product portfolio

7.16. Teleflex Incorporated

7.16.1. Company overview
7.16.2. Company snapshot
7.16.3. Operating business segments
7.16.4. Product portfolio
7.16.5. Business performance
7.16.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL ANESTHESIA AND RESPIRATORY DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 02. GLOBAL ANESTHESIA DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 03. ANESTHESIA DELIVERY MACHINES ANESTHESIA DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 04. ANESTHESIA DISPOSABLES & ACCESSORIES ANESTHESIA DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 05. ANESTHESIA DISPOSABLES & ACCESSORIES ANESTHESIA DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 06. ANESTHESIA MONITORS ANESTHESIA DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 07. ANESTHESIA MONITORS ANESTHESIA DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 08. ANESTHESIA INFORMATION MANAGEMENT SYSTEMS ANESTHESIA DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 09. GLOBAL RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 10. FEW EXAMPLES OF TECHNOLOGICALLY ADVANCED PRODUCTS IN THE THERAPEUTIC DEVICES MARKET
TABLE 11. GLOBAL RESPIRATORY THERAPEUTIC DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12. RESPIRATORY THERAPEUTIC DEVICES MARKET, BY REGION, 2016-2023
TABLE 13. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 14. GLOBAL RESPIRATORY MASKS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 15. GLOBAL VENTILATORS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 16. LIST OF FEW NEBULIZERS AND THEIR COSTS
TABLE 17. GLOBAL OXYGEN CONCENTRATORS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 18. GLOBAL INHALERS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 19. MAJOR TYPES OF DRY POWDER INHALERS
TABLE 20. GLOBAL REUSABLE RESUSCITATORS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 21. TYPES OF CAPNOGRAPHS
TABLE 22. PERCENTAGE OF GLOBAL SMOKER POPULATION, BY ETHNICITY, 2015
TABLE 23. GLOBAL PULSE OXIMETERS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 24. PULSE OXIMETERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. RESPIRATORY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 26. RESPIRATORY DIAGNOSTIC DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL RESPIRATORY CARE CONSUMABLES AND ACCESSORIES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 28. RESPIRATORY CARE CONSUMABLES AND ACCESSORIES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. MAJOR TYPES OF TRACHEOSTOMY TUBES
TABLE 30. GLOBAL ANESTHESIA AND RESPIRATORY DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. ANESTHESIA AND RESPIRATORY MARKET FOR AMBULATORY SERVICE CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 32. ANESTHESIA AND RESPIRATORY MARKET FOR AMBULATORY SERVICE CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 33. ANESTHESIA AND RESPIRATORY MARKET FOR HOMECARE, BY REGION, 2014-2022 ($MILLION)
TABLE 34. ANESTHESIA AND RESPIRATORY DEVICES MARKET FOR CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 35. ANESTHESIA AND RESPIRATORY DEVICES MARKET SEGMENTATION MARKET, BY REGION, 2012-2023 ($MILLION)
TABLE 36. NORTH AMERICA ANESTHESIA AND RESPIRATORY DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. NORTH AMERICA ANESTHESIA DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 38. NORTH AMERICA ANESTHESIA DEVICES MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 39. NORTH AMERICA ANESTHESIA DEVICES MARKET, BY PRODUCT TYPE 2016-2023 ($MILLION)
TABLE 40. EUROPE ANESTHESIA AND RESPIRATORY DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 41. EUROPE ANESTHESIA DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 42. EUROPE ANESTHESIA DEVICES MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 43. EUROPE ANESTHESIA DEVICES MARKET, BY PRODUCT TYPE 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC ANESTHESIA AND RESPIRATORY DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC ANESTHESIA DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC ANESTHESIA DEVICES MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC RESPIRATORY DEVICES MARKET, BY PRODUCT TYPE 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC ANESTHESIA DEVICES MARKET, BY PRODUCT TYPE 2016-2023 ($MILLION)
TABLE 49. LAMEA ANESTHESIA AND RESPIRATORY DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 50. LAMEA ANESTHESIA DEVICES MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 51. LAMEA ANESTHESIA DEVICES MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 52. LAMEA ANESTHESIA DEVICES MARKET, BY PRODUCT TYPE 2016-2023 ($MILLION)
TABLE 53. 3M: COMPANY SNAPSHOT
TABLE 54. 3M: OPERATING SEGMENTS
TABLE 55. 3M: PRODUCT PORTFOLIO
TABLE 56. AMBU: COMPANY SNAPSHOT
TABLE 57. AMBU: OPERATING SEGMENTS
TABLE 58. AMBU: PRODUCT PORTFOLIO
TABLE 59. BD: COMPANY SNAPSHOT
TABLE 60. BD: OPERATING SEGMENTS
TABLE 61. BD: PRODUCT PORTFOLIO
TABLE 62. CHART INDUSTRIES: COMPANY SNAPSHOT
TABLE 63. CHART INDUSTRIES: OPERATING SEGMENTS
TABLE 64. CHART INDUSTRIES: PRODUCT PORTFOLIO
TABLE 65. DRÄGER: COMPANY SNAPSHOT
TABLE 66. DRÄGER: PRODUCT PORTFOLIO
TABLE 67. FISHER & PAYKEL: COMPANY SNAPSHOT
TABLE 68. FISHER & PAYKEL: OPERATING SEGMENTS
TABLE 69. FISHER & PAYKEL: PRODUCT PORTFOLIO
TABLE 70. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 71. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 72. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 73. HAMILTON: COMPANY SNAPSHOT
TABLE 74. HAMILTON: PRODUCT PORTFOLIO
TABLE 75. INVACARE: COMPANY SNAPSHOT
TABLE 76. INVACARE: OPERATING SEGMENTS
TABLE 77. INVACARE: PRODUCT PORTFOLIO
TABLE 78. PHILIPS: COMPANY SNAPSHOT
TABLE 79. PHILIPS: OPERATING SEGMENTS
TABLE 80. PHILIPS: PRODUCT PORTFOLIO
TABLE 81. MASIMO: COMPANY SNAPSHOT
TABLE 82. MASIMO: PRODUCT PORTFOLIO
TABLE 83. MEDTRONIC: COMPANY SNAPSHOT
TABLE 84. MEDTRONIC: OPERATING SEGMENTS
TABLE 85. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 86. RESMED: COMPANY SNAPSHOT
TABLE 87. RESMED: PRODUCT PORTFOLIO
TABLE 88. SMITHS: COMPANY SNAPSHOT
TABLE 89. SMITHS: OPERATING SEGMENTS
TABLE 90. SMITHS: PRODUCT PORTFOLIO
TABLE 91. SUNMED: COMPANY SNAPSHOT
TABLE 92. SUNMED: OPERATING SEGMENTS
TABLE 93. SUNMED: PRODUCT PORTFOLIO
TABLE 94. TELEFLEX: COMPANY SNAPSHOT
TABLE 95. TELEFLEX: OPERATING SEGMENTS
TABLE 96. TELEFLEX: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL ANESTHESIA AND RESPIRATORY DEVICES MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, BY YEAR, 2015-2017
FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2017 (%)
FIGURE 04. TOP WINNING STRATEGIES, BY COMPANY, 2015-2017
FIGURE 05. TOP INVESTMENT POCKETS FOR ANESTHESIA AND RESPIRATORY DEVICES
FIGURE 06. TOP PLAYER POSITIONING, 2016
FIGURE 07. BARGAINING POWER OF BUYERS
FIGURE 08. BARGAINING POWER OF SUPPLIERS
FIGURE 09. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. GLOBAL ANESTHESIA CIRCUITS MARKET, 2016-2023 ($MILLION)
FIGURE 13. GLOBAL ANESTHESIA MASKS MARKET, 2016-2023 ($MILLION)
FIGURE 14. GLOBAL RESUSCITATORS MARKET, 2016-2023 ($MILLION)
FIGURE 15. GLOBAL LARYNGOSCOPE MARKET, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL FLEXIBLE INTUBATION SCOPES MARKET, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL SUPRAGLOTIC AIRWAYS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL VENTILATOR CIRCUITS MARKET, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL HEAT AND MOISTURE EXCHANGERS MARKET, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL REGIONAL ANESTHESIA AND PAIN DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL OTHER ANESTHESIA DISPOSABLE AND ACCESSORIES MARKET, 2016-2023 ($MILLION)
FIGURE 22. GLOBAL BASIC ANESTHESIA MONITORS MARKET, 2016-2023 ($MILLION)
FIGURE 23. GLOBAL ADVANCED ANESTHESIA MACHINES MARKET, 2016-2023 ($MILLION)
FIGURE 24. GLOBAL INTEGRATED ANESTHESIA WORKSTATION MARKET, 2016-2023 ($MILLION)
FIGURE 25. GLOBAL PREVALENCE OF SLEEP APNEA, 2013
FIGURE 26. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 27. GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BPAP) DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 28. GLOBAL AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 29. GLOBAL NASAL MASKS MARKET, 2016-2023 ($MILLION)
FIGURE 30. GLOBAL FULL-FACE MASKS MARKET, 2016-2023 ($MILLION)
FIGURE 31. GLOBAL NASAL PILLOW MASKS MARKET, 2016-2023 ($MILLION)
FIGURE 32. GLOBAL ORAL MASK MARKET, 2016-2023 ($MILLION)
FIGURE 33. GLOBAL ADULT VENTILATORS MARKET, 2016-2023 ($MILLION)
FIGURE 34. GLOBAL INFANT/NEONATAL VENTILATORS MARKET, 2016-2023 ($MILLION)
FIGURE 35. GLOBAL NEBULIZERS MARKET, 2016-2023 ($MILLION)
FIGURE 36. GLOBAL HUMIDIFIERS MARKET, 2016-2023 ($MILLION)
FIGURE 37. GLOBAL GERIATRIC POPULATION (BILLION)
FIGURE 38. GLOBAL FIXED OXYGEN CONCENTRATORS MARKET, 2016-2023 ($MILLION)
FIGURE 39. GLOBAL PORTABLE OXYGEN CONCENTRATORS MARKET, 2016-2023 ($MILLION)
FIGURE 40. GLOBAL DRY POWDER INHALERS MARKET, 2016-2023 ($MILLION)
FIGURE 41. GLOBAL METERED DOSE INHALERS MARKET, 2016-2023 ($MILLION)
FIGURE 42. GLOBAL SOFT MIST INHALERS MARKET, 2016-2023 ($MILLION)
FIGURE 43. GLOBAL ADULT RESUSCITATORS MARKET, 2016-2023 ($MILLION)
FIGURE 44. GLOBAL INFANT/NEONATAL RESUSCITATORS MARKET, 2016-2023 ($MILLION)
FIGURE 45. GLOBAL NITRIC OXIDE DELIVERY UNITS MARKET, 2016-2023 ($MILLION)
FIGURE 46. GLOBAL CAPNOGRAPHS MARKET, 2016-2023 ($MILLION)
FIGURE 47. GLOBAL GAS ANALYZERS MARKET, 2016-2023 ($MILLION)
FIGURE 48. GLOBAL OXYGEN HOODS MARKET, 2016-2023 ($MILLION)
FIGURE 49. GLOBAL PEDIATRIC PULSE OXIMETERS MARKET, 2016-2023 ($MILLION)
FIGURE 50. GLOBAL WRIST-WORN PULSE OXIMETERS MARKET, 2016-2023 ($MILLION)
FIGURE 51. GLOBAL HANDHELD PULSE OXIMETERS MARKET, 2016-2023 ($MILLION)
FIGURE 52. GLOBAL FINGERTIP PULSE OXIMETERS MARKET, 2016-2023 ($MILLION)
FIGURE 53. GLOBAL TABLE-TOP OR BEDSIDE PULSE OXIMETERS MARKET, 2016-2023 ($MILLION)
FIGURE 54. GLOBAL SPIROMETERS MARKET, 2016-2023 ($MILLION)
FIGURE 55. GLOBAL POLYSOMNOGRAPHY (PSG) DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 56. GLOBAL PEAK FLOW METERS MARKET, 2016-2023 ($MILLION)
FIGURE 57. GLOBAL DISPOSABLE MASKS MARKET, 2016-2023 ($MILLION)
FIGURE 58. GLOBAL DISPOSABLE RESUSCITATORS MARKET, 2016-2023 ($MILLION)
FIGURE 59. GLOBAL TRACHEOSTOMY TUBES MARKET, 2016-2023 ($MILLION)
FIGURE 60. GLOBAL NASAL CANNULAS MARKET, 2016-2023 ($MILLION)
FIGURE 61. GLOBAL OTHER CONSUMABLES AND ACCESSORIES MARKET, 2016-2023 ($MILLION)
FIGURE 62. U.S. ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 63. CANADA ANESTHESIA AND RESPIRATORY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 64. MEXICO ANESTHESIA AND RESPIRATORY DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 65. GERMANY ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 66. FRANCE ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 67. UK ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 68. ITALY ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 69. SPAIN ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 70. REST OF THE EUROPE ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 71. JAPAN ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 72. CHINA ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 73. AUSTRALIA ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 74. INDIA ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 75. SOUTH KOREA ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 76. REST OF THE ASIA-PACIFIC ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 77. BRAZIL ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 78. SAUDI ARABIA ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 79. SOUTH AFRICA ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 80. REST OF LAMEA ANESTHESIA DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 81. 3M: NET SALES, 2014-2016 ($MILLION)
FIGURE 82. 3M: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 83. 3M: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 84. AMBU: NET SALES, 2015-2017 ($MILLION)
FIGURE 85. AMBU: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 86. AMBU: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 87. BD: NET SALES, 2015-2017 ($MILLION)
FIGURE 88. BD: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 89. BD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 90. CHART INDUSTRIES: NET SALES, 2014-2016 ($MILLION)
FIGURE 91. CHART INDUSTRIES: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 92. CHART INDUSTRIES: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 93. DRÄGER: NET SALES, 2014-2016 ($MILLION)
FIGURE 94. DRÄGER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 95. FISHER & PAYKEL: NET SALES, 2015-2017 ($MILLION)
FIGURE 96. FISHER & PAYKEL: REVENUE SHARE BY PRODUCT CATEGORY, 2017 (%)
FIGURE 97. FISHER & PAYKEL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 98. GE HEALTHCARE: NET SALES, 2014-2016 ($MILLION)
FIGURE 99. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 100. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 101. INVACARE: NET SALES, 2014-2016 ($MILLION)
FIGURE 102. INVACARE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 103. PHILIPS: NET SALES, 2014-2016 ($MILLION)
FIGURE 104. PHILIPS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 105. MASIMO: NET SALES, 2014-2016 ($MILLION)
FIGURE 106. MASIMO: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 107. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 108. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 109. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 110. RESMED: NET SALES, 2015-2017 ($MILLION)
FIGURE 111. RESMED: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 112. SMITHS: NET SALES, 2015-2017 ($MILLION)
FIGURE 113. SMITHS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 114. SMITHS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 115. TELEFLEX: NET SALES, 2014-2016 ($MILLION)
FIGURE 116. TELEFLEX: REVENUE SHARE BY SEGMENT, 2016 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Have a question ?

Need to add more ?

Featured Readings

Get Fresh Content Delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Get Industry Data Alerts >